Article
Hematology
Guangqiang Meng, Jingshi Wang, Tingting Cui, Zhao Wang
Summary: Natural killer (NK)/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis (NK/T-LAHLH) is a rare and life-threatening disorder. The clinical characteristics and appropriate treatment options for this disease are still unclear. This study found that patients with NK/T-LAHLH were younger and had more severe clinical features, while the L-DEP/DEP regimen may have a better response rate than the VP-16 + dexamethasone-based regimens.
ANNALS OF HEMATOLOGY
(2022)
Review
Biochemistry & Molecular Biology
FengXia Gao, SiRong He, AiShun Jin
Summary: lncRNAs and miRNAs play significant roles in NK cell biology and diseases, serving as potential biomarkers/targets for early diagnosis, targeted treatment, and prognostic evaluations of NKTL.
Article
Nutrition & Dietetics
Tiange Lu, Xue Shi, Xueling Ge, Ying Li, Yiqing Cai, Xiaomin Chen, Shunfeng Hu, Mei Ding, Xiaosheng Fang, Fang Liu, Xiangxiang Zhou, Xin Wang
Summary: In this study, the significance of nutritional status in extranodal NK/T-cell lymphoma (ENKTL) was explored, and a new scoring system (CONUT-PINK-E) was developed to assess patients' nutritional status and prognosis. The results showed that CONUT-PINK-E could independently predict patients' overall survival and progression-free survival, and presented superior discrimination and clinical benefit compared to current models.
FRONTIERS IN NUTRITION
(2023)
Article
Oncology
Danian Nie, Xiaohui Xiao, Jiaoting Chen, Shuangfeng Xie, Jie Xiao, Wenjuan Yang, Hongyun Liu, Jieyu Wang, Liping Ma, Yumo Du, Kezhi Huang, Yiqing Li
Summary: This study found that high expression of XPO1 is associated with poor prognosis in T-cell lymphoma and demonstrated the anti-tumor activity of the selective nuclear export inhibitor KPT-8602 in TCL cells.
EXPERIMENTAL CELL RESEARCH
(2022)
Article
Oncology
Xiaoyan Feng, Miaomiao Meng, Hongwen Li, Yuyang Gao, Wenting Song, Ruiqing Di, Zhaoming Li, Xudong Zhang, Mingzhi Zhang
Summary: Natural killer/T-cell lymphoma (NKTCL) is an incurable aggressive T-cell lymphoma closely correlated with Epstein-Barr virus (EBV) infection. T-cell dysfunction and accumulation of inhibitory cell components were observed in NKTCL patients, including higher frequencies of inhibitory T regulatory cells (Tregs) and myeloid-derived suppressor cells (MDSCs), altered T-cell distribution, higher expression levels of multiple surface inhibitory receptors (IRs) in T cells, reduced T-cell proliferation and interferon-gamma production, lower number of EBV-specific cytotoxic cells with upregulated IRs and decreased effector cytokine secretion. Additionally, NKTCL cells induced T-cell exhaustion phenotypes, generation of Tregs and MDSCs in normal PBMCs.
Article
Oncology
Eun Kyung Kim, Mi Jang, Woo Ick Yang, Sun Och Yoon
Summary: Primary gastrointestinal T/NK cell lymphoma (GI-TNKL) is a rare and heterogeneous group of lymphoid malignancies, with unique subtypes showing specific characteristics. Predominantly affecting adults, particularly males, the most common histologic types are ENKTL and MEITL, primarily in the small intestine. Patients typically present with GI symptoms, and cases with advanced disease may require emergency surgery. GI-TNKL exhibits aggressive behavior and has short progression-free survival and overall survival.
Review
Oncology
Zanelli Magda, Paola Parente, Francesca Sanguedolce, Maurizio Zizzo, Andrea Palicelli, Alessandra Bisagni, Illuminato Carosi, Domenico Trombetta, Luca Mastracci, Linda Ricci, Saverio Pancetti, Giovanni Martino, Giuseppe Broggi, Rosario Caltabiano, Alberto Cavazza, Stefano Ascani
Summary: Intravascular NK/T-cell lymphoma is a rare lymphoma with unique clinical, pathological, and molecular features, posing challenges in diagnosis and treatment. EBV infection is closely associated with the aggressive behavior of the disease, and immune checkpoint inhibitors may offer promising therapeutic results.
Review
Immunology
Massimiliano Gambella, Simona Carlomagno, Anna Maria Raiola, Livia Giannoni, Chiara Ghiggi, Chiara Setti, Chiara Giordano, Silvia Luchetti, Alberto Serio, Alessandra Bo, Michela Falco, Mariella Della Chiesa, Emanuele Angelucci, Simona Sivori
Summary: Surgical resection, chemotherapy, and radiotherapy have been the primary cancer treatments for a long time. Recently, immune checkpoint inhibitors and adoptive cell therapies have emerged as promising alternatives. These therapies aim to activate and utilize the patient's immune system to fight against cancer cells, and have shown remarkable results.
FRONTIERS IN IMMUNOLOGY
(2022)
Article
Dermatology
Yumei Gao, Fengjie Liu, Jingru Sun, Yujie Wen, Ping Tu, Marshall E. Kadin, Yang Wang
Summary: SATB1 expression is associated with clinicopathological characteristics in MF, with high expression correlating with favorable prognosis and low expression potentially linked to poor outcomes. SATB1 may influence pathology and outcomes in MF patients by regulating gene expression and immune activation.
JOURNAL OF INVESTIGATIVE DERMATOLOGY
(2021)
Article
Oncology
Yang Chunli, Jiang Ming, Ma Ziyan, Ji Jie, Lv Shuli, Huang Jie, Wu Yu, Xu Caigang, Zou Liqun
Summary: This study aimed to summarize the clinical features and survival outcomes of primary gastrointestinal natural killer (NK)/T-cell lymphoma (PGINKTL). The review of cases revealed that PGINKTL is a rare and fatal lymphoma type, with diverse clinical symptoms and lesion sites. Treatment strategies and survival prognosis play a crucial role in patients.
Article
Oncology
Chong Wei, Wei Li, Liping Qin, Shan Liu, Chang Xue, Kexing Ren, Zirong Zhang, Caili Liu, Fang Bao, Huilai Zhang, Hui Zhou, Zhiming Li, Huijing Wu, Liqun Zou, Lihong Liu, Hongmei Jing, Wei Zhang
Summary: This study aimed to characterize the clinicopathologic features, prognosis, and prognostic factors of AITL in China. The majority of Chinese AITL patients were treated with anthracycline-based regimens, but the outcomes were still unsatisfactory. A novel prognostic model (the Chinese AITL score) was developed to better identify patients at different risks for alternative therapies.
Review
Oncology
Ajay Major, Pierluigi Porcu, Bradley M. Haverkos
Summary: This review summarizes the research on the biological causes of ENKTL and the identification of new therapeutic targets and biomarkers, which may enable a personalized medicine approach towards ENKTL therapy.
Article
Oncology
Akhil Rajendra, Manju Sengar, V. N. Avinash Bonda, Hasmukh Jain, Lingaraj Nayak, Jayashree Thorat, Tanuja Shet, Sridhar Epari, Siddharth Laskar, Archi Aggarwal, V. Rangarajan, Sumeet Gujral, Bhausaheb Bagal, Sangeeta Kakoti, Omkar Salvi
Summary: The staging, prognostication, and treatment of ENKTL have evolved with better understanding of disease biology. There is significant heterogeneity in the treatment used worldwide. This study investigated the outcomes and prognostic factors of ENKTL patients treated at a center in India between 2010 and 2021. The results showed that L-asparaginase based chemotherapy was administered to 84% of patients, and the median relapse-free survival and overall survival were 45 months for the overall population. PINK score, receipt of radiotherapy, and achievement of complete response were identified as prognostic factors for survival.
LEUKEMIA & LYMPHOMA
(2023)
Article
Oncology
Akhil Rajendra, Manju Sengar, V. N. Avinash Bonda, Hasmukh Jain, Lingaraj Nayak, Jayashree Thorat, Tanuja Shet, Sridhar Epari, Siddharth Laskar, Archi Aggarwal, V. Rangarajan, Sumeet Gujral, Bhausaheb Bagal, Sangeeta Kakoti, Omkar Salvi
Summary: The staging, prognostication, and treatment of ENKTL have improved over the years with a better understanding of the disease biology. There is significant heterogeneity in the treatment strategies used worldwide. In this study, we examined the outcomes and prognostic factors of ENKTL patients treated at our center between May 2010 and December 2021. L-asparaginase based chemotherapy was administered to 84% of the patients.
LEUKEMIA & LYMPHOMA
(2023)
Article
Oncology
Yu-Ting Zhao, Si-Ye Chen, Xin Liu, Yong Yang, Bo Chen, Yong-Wen Song, Hui Fang, Jing Jin, Yue-Ping Liu, Hao Jing, Yuan Tang, Ning Li, Ning-Ning Lu, Shu-Lian Wang, Han Ouyang, Chen Hu, Jin Liu, Zhi Wang, Fan Chen, Lin Yin, Qiu-Zi Zhong, Kuo Men, Jian-Rong Dai, Shu-Nan Qi, Ye-Xiong Li
Summary: This study aimed to assess the value of multi-modal MRI-based radiomics for predicting overall survival in patients with ENKTCL. Two distinct types of MRI radiomics signatures were identified, and the NRI-M model showed better performance in prognostication compared to traditional risk indices.
Article
Medicine, General & Internal
Hyerim Ha, Bhumsuk Keam, Chan-Young Ock, Tae Min Kim, Jin Ho Kim, Eun-Jae Chung, Seong Keun Kwon, Soon-Hyun Ahn, Hong-Gyun Wu, Myung-Whun Sung, Dae Seog Heo
Summary: The study demonstrated that concurrent chemoradiation with cisplatin is effective for local control of locally advanced unresectable ACC, achieving high rates of complete remission with manageable toxicity.
KOREAN JOURNAL OF INTERNAL MEDICINE
(2021)
Article
Medicine, General & Internal
Chang Hyun Nam, Jaemoon Koh, Chan-Young Ock, Miso Kim, Bhumsuk Keam, Tae Min Kim, Yoon Kyung Jeon, Dong-Wan Kim, Doo Hyun Chung, Dae Seog Heo
Summary: The study found that about one-fourth of non-small cell lung cancer patients experienced changes in their PD-L1 expression status. Patients with PD-L1 positivity in either archival or recent samples showed better responses to immune checkpoint inhibitors and longer overall survival after platinum failure compared to those who maintained PD-L1 negativity.
KOREAN JOURNAL OF INTERNAL MEDICINE
(2021)
Article
Oncology
Changhee Park, Kyeonghun Jeong, Joon-Hyeong Park, Sohee Jung, Jeong Mo Bae, Kwangsoo Kim, Chan-Young Ock, Miso Kim, Bhumsuk Keam, Tae Min Kim, Yoon Kyung Jeon, Se-Hoon Lee, Ju-Seog Lee, Dong-Wan Kim, Gyeong Hoon Kang, Doo Hyun Chung, Dae Seog Heo
Summary: The study demonstrated a negative correlation between overall methylation aberrancy and tumor immunogenicity, indicating the importance of methylation aberrancy for tumors to evade immune surveillance. This highlights the need for further development of methylation biomarkers in cancer research.
CANCER IMMUNOLOGY IMMUNOTHERAPY
(2021)
Article
Oncology
Shin Hye Yoo, Jihui Yun, Bhumsuk Keam, Seung-Pyo Hong, Chan-Young Ock, Jaemoon Koh, Sehui Kim, Yoon Kyung Jeon, Kyeong Cheon Jung, Miso Kim, Tae Min Kim, Dong-Wan Kim, Jong-Il Kim, Dae Seog Heo
Summary: The increase in immunosuppressive markers observed after ICI treatment may contribute to acquired resistance (AR), and APOBEC-mediated PIK3CA mutation could be another mechanism of AR. Further studies with sufficient sample size are needed to validate these mechanisms.
CANCER IMMUNOLOGY IMMUNOTHERAPY
(2021)
Article
Oncology
Dalyong Kim, Shin Hye Yoo, Seyoung Seo, Hyun Jung Lee, Min Sun Kim, Sung Joon Shin, Chi-Yeon Lim, Do Yeun Kim, Dae Seog Heo, Chae-Man Lim
Summary: This study analyzed the decision-making patterns for life-sustaining treatment (LST) and medical service utilization changes after the enforcement of the Life-Sustaining Treatment Decision-Making Act. The results showed that the cancer patient's own decision-making was associated with earlier decision-making, less use of certain critical treatments, and lower medical costs.
CANCER RESEARCH AND TREATMENT
(2022)
Article
Oncology
Chaelin Lee, Miso Kim, Dong-Wan Kim, Tae Min Kim, Soyeon Kim, Sun-Wha Im, Yoon Kyung Jeon, Bhumsuk Keam, Ja-Lok Ku, Dae Seog Heo
Summary: This study reveals that the T790M mutation in EGFR-KDD confers resistance to 1st and 2nd generation EGFR tyrosine kinase inhibitors (TKIs), but is sensitive to 3rd generation EGFR TKIs. In addition, the study identifies that the C797S mutation in kinase domain 2 of EGFR-KDDT790M mediates a resistance mechanism against 3rd generation EGFR TKIs.
CANCER RESEARCH AND TREATMENT
(2022)
Article
Critical Care Medicine
Jun Won Park, Jeffrey R. Curtis, Kang Il Jun, Tae Min Kim, Dae Seog Heo, Jongwon Ha, Kyung-Suk Suh, Kwang-Woong Lee, Hajeong Lee, Jaeseok Yang, Min Jung Kim, Yunhee Choi, Eun Bong Lee
Summary: The use of TMP-SMX prophylaxis significantly reduces the incidence of PJP in patients receiving rituximab treatment, with an acceptable safety profile.
Article
Multidisciplinary Sciences
So Yeon Oh, Soyeon Kim, Bhumsuk Keam, Tae Min Kim, Dong-Wan Kim, Dae Seog Heo
Summary: The study revealed that high levels of sPD-L1 in cancer patients were associated with progressive disease and worse prognosis, as well as positively correlated with neutrophil to lymphocyte ratios and negatively correlated with lymphocyte proportions and total numbers.
SCIENTIFIC REPORTS
(2021)
Article
Multidisciplinary Sciences
Ha-Ram Park, Seong-Eun Kim, Bhumsuk Keam, Hyewon Chung, Seung Hyeok Seok, Soyeon Kim, Miso Kim, Tae Min Kim, Junsang Doh, Dong-Wan Kim, Dae Seog Heo
Summary: This study provides evidence that anti-CD47 blocking antibodies enhance the antitumor effect of macrophages in renal cell carcinoma (RCC), and their combination with VEGFR TKIs can be a potential therapeutic strategy.
SCIENTIFIC REPORTS
(2022)
Article
Health Care Sciences & Services
Jung Sun Kim, Sun Young Lee, Min Sung Lee, Shin Hye Yoo, Jeongmi Shin, Wonho Choi, Yejin Kim, Hyung Sook Han, Jinui Hong, Bhumsuk Keam, Dae Seog Heo
Summary: This study investigated the characteristics of end-of-life care for dying patients in the emergency department (ED) of a tertiary hospital in Korea. The findings showed that patients in the ED received more aggressive care and less comfort care, with lower involvement of palliative care teams. Younger patients and those who completed life-sustaining treatment legal forms received more comfort care.
BMC PALLIATIVE CARE
(2022)
Article
Infectious Diseases
Jeong-Han Kim, Shin Hye Yoo, Bhumsuk Keam, Dae Seog Heo
Summary: Palliative care consultation may reduce aggressive antibiotic use in hospitalized patients with terminal cancer during the end-of-life phase.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
(2023)
Article
Oncology
Jeongjae Lee, Bhumsuk Keam, Ha-Ram Park, Ji-Eun Park, Soyeon Kim, Miso Kim, Tae Min Kim, Dong-Wan Kim, Dae Seog Heo
Summary: This study found a correlation between HLA-E surface expression in head and neck squamous cell carcinoma cell lines and the efficacy of the NKG2A inhibitor, monalizumab, in promoting NK cell activity. Cell lines with high HLA-E expression showed stronger inhibition of NK cell cytotoxicity and had higher efficacy of monalizumab. Combination with cetuximab increased the effectiveness of monalizumab. Stimulation of isolated NK cells with IL-2 and IL-15 also increased the efficacy of monalizumab, even in the HLA-E low groups.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
(2023)
Article
Oncology
Jeongjae Lee, Bhumsuk Keam, Soyeon Kim, Jung-Nyoung Heo, Eunkyo Joung, Miso Kim, Tae Min Kim, Dong-Wan Kim, Dae Seog Heo
Summary: A novel GCN2 inhibitor, AST-0513, was found to inhibit the GCN2-ATF4 pathway, reduce proliferation, induce cell cycle arrest and apoptosis in head and neck squamous cell carcinoma cell lines, suggesting its potential as a therapeutic option.
TRANSLATIONAL ONCOLOGY
(2023)
Meeting Abstract
Oncology
S. Oh, J. Koh, T. M. Kim, S. Kim, J. Youk, M. Kim, B. Keam, Y. K. Jeon, D. W. Kim, D. S. Heo
EUROPEAN JOURNAL OF CANCER
(2022)
Meeting Abstract
Oncology
S. Park, T. M. Kim, S. Kim, M. Kim, B. Keam, D. W. Kim, D. S. Heo
EUROPEAN JOURNAL OF CANCER
(2022)